JACC Deep Dive podcast artwork
Health & Fitness

JACC Deep Dive

by American College of Cardiology
Claiming needs an RSS feed. Contact us.

Recently ranked · United States

Last recorded placements from this show’s chart history. These are not current rankings.

Not on the United States charts we track today.

If you like JACC Deep Dive, try…

Latest episodes

Show 7 more episodesShow fewer episodes
  • Master DAPT | JACC Deep Dive

    August 11, 2025 · 7 min

    In this episode of JACC Deep Dive, Dr. Harlan Krumholz explores new insights from a post hoc analysis of the MASTER DAPT trial, highlighting the real-world burden of ischemic and bleeding events in high bleeding risk patients after PCI. By…

  • Cardiac Biomarkers in ATTR-CM From HELIOS-B | JACC Deep Dive

    August 4, 2025 · 7 min

    In this episode of JACC Deep Dive, KACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC,  explores a post hoc analysis of the HELIOS-B trial, which examined whether echocardiographic parameters can track treatment response in…

  • Insights From the INTERASPIRE Study | JACC Deep Dive

    July 31, 2025 · 11 min

    JACC focuses in again on Lipids in our June 3 issue, bringing critical insights into emerging targeted therapies. In the June 3 Deep Dive, editor-in-chief Harlan M. Krumholz, MD, SM, FACC, reviews the INTERASPIRE study by Ray et al…

  • Vutrisiran Impact on Functional Capacity and QOL | JACC Deep Dive | JACC

    July 31, 2025 · 8 min

    Go behind the scenes with JACC as editor-in-chief Harlan M. Krumholz, MD, SM, FACC, talks about what 's caught his attention in the latest JACC issue on amyloid. In this paper by Sheikh et al, the authors did a pre-specified exploratory…

  • Individual Variation in Tirzepatide Response | JACC Deep Dive

    July 31, 2025 · 8 min

    Join JACC Editor in Chief Harlan Krumholz, MD, SM, as he speaks about this ACC.25 presentation published in JACC. This fascinating study by Rohan Khera et al independently analyzed patient-level data from the SURMOUNT trials of tirzepatide…

  • Revisiting the SUMMIT Trial | JACC Deep Dive

    July 31, 2025 · 6 min

    This JACC Deep Dive in our May 13 issue highlights new findings from the SUMMIT CKD study, showing that terzepatide improves symptoms, function, and weight in patients with HFpEF and obesity—regardless of kidney function. The analysis also…

  • 1-Year Results of ADVANTAGE AF | JACC Deep Dive

    July 31, 2025 · 7 min

    In this JACC Deep Dive episode, Dr. Harlan Krumholz reviews the ADVANTAGE-AF trial, which evaluated pulse field ablation (PFA) as a treatment for persistent atrial fibrillation. The study demonstrated that PFA is a safe and effective…

Full episode archive on Apple Podcasts →

About the show

JACC Deep Dive explores the methodology, interpretation, and impact of key studies published in JACC.